olanzapine

Ukraine

Drugs containing this active substance

  • ADAGIO®

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent episodes in patients with bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 10 mg

    ATC: N05AH03

    Manufacturer: Farmak JSC

  • ADAJIO®

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 5 mg

    ATC: N05AH03

    Manufacturer: Farmak JSC

  • ADAJIO®

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent episodes in patients with bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 2.5 mg

    ATC: N05AH03

    Manufacturer: Farmak JSC

  • EGOLANZA

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent episodes in bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 5 mg

    ATC: N05AH03

    Manufacturer: PJSC Pharmaceutical Plant EGIS

  • EGOLANZA

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent episodes in bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 10 mg

    ATC: N05AH03

    Manufacturer: PJSC Pharmaceutical Plant EGIS

  • EGOLANZA

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 15 mg

    ATC: N05AH03

    Manufacturer: PJSC Pharmaceutical Plant EGIS

  • EGOLANZA

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 20 mg

    ATC: N05AH03

    Manufacturer: PJSC Pharmaceutical Plant EGIS

  • JUBREKSA

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, dispersible in the oral cavity

    Active substance Dosage
    olanzapine 10 mg

    ATC: N05AH03

    Manufacturer: Jubilant Generics Limited

  • JUBREKSA

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent episodes in patients with bipolar disorders.

    Form: tablets, dispersible in the oral cavity

    Active substance Dosage
    olanzapine 15 mg

    ATC: N05AH03

    Manufacturer: Jubilant Generics Limited

  • JUBREXA

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent episodes in patients with bipolar disorders.

    Form: tablets, dispersible in the oral cavity

    Active substance Dosage
    olanzapine 5 mg

    ATC: N05AH03

    Manufacturer: Jubilant Generics Limited

  • JUBREXA

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, dispersible in the oral cavity

    Active substance Dosage
    olanzapine 20 mg

    ATC: N05AH03

    Manufacturer: Jubilant Generics Limited

  • OLFLEX

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 5 mg

    ATC: N05AH03

    Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.

  • OLFLEX

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 10 mg

    ATC: N05AH03

    Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.

  • TOLANZ 10

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, dispersible in the oral cavity

    Active substance Dosage
    olanzapine 10 mg

    ATC: N05AH03

    Manufacturer: Torrent Pharmaceuticals Ltd

  • TOLANZ 5

    The drug is intended for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, dispersible in the oral cavity

    Active substance Dosage
    olanzapine 5 mg

    ATC: N05AH03

    Manufacturer: Torrent Pharmaceuticals Ltd

  • ZALASTA

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent manic episodes in patients with bipolar disorders.

    Form: tablets

    Active substance Dosage
    olanzapine 7.5 mg

    ATC: N05AH03

    Manufacturer: KRKA, d.d., Novo mesto

  • ZALASTA

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent manic episodes in patients with bipolar disorders.

    Form: tablets

    Active substance Dosage
    olanzapine 10 mg

    ATC: N05AH03

    Manufacturer: KRKA, d.d., Novo mesto

  • ZALASTA

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent manic episodes in patients with bipolar disorders.

    Form: tablets

    Active substance Dosage
    olanzapine 15 mg

    ATC: N05AH03

    Manufacturer: KRKA, d.d., Novo mesto

  • ZALASTA®

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent manic episodes in patients with bipolar disorders.

    Form: tablets

    Active substance Dosage
    olanzapine 2.5 mg

    ATC: N05AH03

    Manufacturer: KRKA, d.d., Novo mesto

  • ZALASTA®

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent manic episodes in patients with bipolar disorders.

    Form: tablets

    Active substance Dosage
    olanzapine 5 mg

    ATC: N05AH03

    Manufacturer: KRKA, d.d., Novo mesto

  • ZALASTA®

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent manic episodes in patients with bipolar disorders.

    Form: tablets

    Active substance Dosage
    olanzapine 20 mg

    ATC: N05AH03

    Manufacturer: KRKA, d.d., Novo mesto

  • ZOLAFRAN FAST

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, dispersible in the oral cavity

    Active substance Dosage
    olanzapine 10 mg

    ATC: N05AH03

    Manufacturer: JSC "Adamed Pharma" (manufacturer responsible for batch release and control; manufacturing "in bulk", primary and secondary packaging)

  • ZOLAFRAN FAST

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent episodes in patients with bipolar disorders.

    Form: tablets, dispersible in the oral cavity

    Active substance Dosage
    olanzapine 20 mg

    ATC: N05AH03

    Manufacturer: JSC "Adamed Pharma" (manufacturer responsible for batch release and control; manufacturing "in bulk", primary and secondary packaging)

  • ZOLAFREN

    The drug is indicated for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent attacks in patients with bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 10 mg

    ATC: N05AH03

    Manufacturer: JSC "Adamed Pharma" (quality control, batch release authorization; manufacturer "in bulk", primary and secondary packaging)

  • ZOLAFRIN

    The drug is used for the treatment of schizophrenia, moderate to severe manic episodes, and for the prevention of recurrent episodes in patients with bipolar disorders.

    Form: tablets, film-coated

    Active substance Dosage
    olanzapine 5 mg

    ATC: N05AH03

    Manufacturer: JSC "Adamed Pharma" (quality control, batch release authorization; manufacturer "in bulk", primary and secondary packaging)